Study 301: BLI4900 Versus an FDA-approved Comparator in Adult Subjects Prior to Colonoscopy
Public ClinicalTrials.gov record NCT04446299. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Safety and Efficacy Comparison of BLI4900 Bowel Preparation Versus an FDA-approved Comparator in Adult Subjects Prior to Colonoscopy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to compare the safety and efficacy of BLI4900 bowel preparation to an FDA-approved control as 2-day, split-dose bowel preparations prior to colonoscopy in adult patients.
Study identification
- NCT ID
- NCT04446299
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 519 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 12, 2020
- Primary completion
- Dec 21, 2020
- Completion
- Jan 21, 2021
- Last update posted
- Nov 6, 2023
2020 – 2021
United States locations
- U.S. sites
- 25
- U.S. states
- 16
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| 301 Research Site 18 | Huntsville | Alabama | 38501 | — |
| 301 Research Site 24 | Sun City | Arizona | 85351 | — |
| 301 Research Site 7 | San Diego | California | 92114 | — |
| 301 Research Site 16 | Clearwater | Florida | 33756 | — |
| 301 Research Site 12 | Jacksonville | Florida | 32216 | — |
| 301 Research Site 9 | Palm Harbor | Florida | 34684 | — |
| 301 Research Site 4 | Palmetto Bay | Florida | 33157 | — |
| 301 Research Site 26 | Port Orange | Florida | 32127 | — |
| 301 Research Site 14 | St. Petersburg | Florida | 33709 | — |
| 301 Research Site 25 | Sunrise | Florida | 33351 | — |
| 301 Research Site 2 | Decatur | Georgia | 30033 | — |
| 301 Research Site 10 | Indianapolis | Indiana | 46202 | — |
| 301 Research Site 3 | Monroe | Louisiana | 71201 | — |
| 301 Research Site 17 | Shreveport | Louisiana | 71105 | — |
| 301 Research Site 11 | Flowood | Mississippi | 39232 | — |
| 301 Research Site 13 | Chesterfield | Missouri | 48047 | — |
| 301 Research Site 19 | Reno | Nevada | 89511 | — |
| 301 Research Site 15 | Brooklyn | New York | 11235 | — |
| 301 Research Site 5 | Great Neck | New York | 11023 | — |
| 301 Research Site 23 | New York | New York | 10033 | — |
| 301 Research Site 6 | Raleigh | North Carolina | 27612 | — |
| 301 Research Site 21 | Mentor | Ohio | 44060 | — |
| 301 Research Site 20 | Hixson | Tennessee | 37434 | — |
| 301 Research Site 1 | Ogden | Utah | 84405 | — |
| 301 Research Site 22 | Milwaukee | Wisconsin | 53215 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04446299, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 6, 2023 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04446299 live on ClinicalTrials.gov.